Sitravatinib
#
-
Catalog numberB2539-25
-
Price:
-
Size25 mg
-
-
Alternative_nameMGCD516; MGCD-516; N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; MG516
-
DescriptionSitravatinib (MGCD516; MG516) is a potent receptor tyrosine kinase (RTK) inhibitor with IC₅₀s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT , FLT3, DDR2, DDR1, TRKA, TRKB, respectively.
-
CAS Number1123837-84-2
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₃₃H₂₉F₂N₅O₄S
-
Molecular Weight629.68
-
Cell PermeableTrue
-
Purity≥98%
-
Solubilities>30 mg/ml in DMSO
-
HandlingDo not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
-
Tag LineA potent receptor tyrosine kinase (RTK) inhibitor
-
Storage Condition-20ºC
-
Shipping ConditionGel Pack
-
Shelf Life36 months
-
PubChem CID25212148
-
SMILESCOCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F
-
InChiInChI=1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-15,18H2,1H3,(H,39,41)(H,40,42)
-
InChi KeyWLAVZAAODLTUSW-UHFFFAOYSA-N
-
MSDS AvailableTrue
-
Gene target
-
Short nameSitravatinib
-
Alternative nameSitravatinib
-